Intraoperative IABP and levosimendan use in cardiас surgery

Lomivorotov V.V.; Boboshko V.A.; Boboshko A.V.; Cherniavskiĭ A.M.; Nikolaev D.A.; Kornilov I.A.; Shilova A.N.; Lomivorotov V.N.

doi:https://doi.org/

Lomivorotov V.V.

E.N.Meshalkin National Medical Research Center under the Ministry of Health of the Russia, Novosibirsk, 630055, Russia

ORCID: 0000-0001-8591-6461

Boboshko V.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Boboshko A.V.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Cherniavskiĭ A.M.

Novosibirskiĭ NII patologii krovoobrashcheniia im. akad. E.N. Meshalkina;
Rossiĭskiĭ kardiologicheskiĭ nauchno-proizvodstvennyĭ kompleks Minzdravsotsrazvitiia Rossii, Moskva

Nikolaev D.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Kornilov I.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Shilova A.N.

Department of Vascular Surgery, E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk

Lomivorotov V.N.

FGBU Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina Minzdrava Rossii

Intraoperative IABP and levosimendan use in cardiас surgery

Authors:

Lomivorotov V.V., Boboshko V.A., Boboshko A.V., Cherniavskiĭ A.M., Nikolaev D.A., Kornilov I.A., Shilova A.N., Lomivorotov V.N.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(2): 75‑81

Read: 1396 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Lomivorotov VV, Boboshko VA, Boboshko AV, et al. . Intraoperative IABP and levosimendan use in cardiас surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(2):75‑81. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Prediction of myocardial contractility after coronary bypass surgery according to preoperative contrast-enhanced cardiac magnetic resonance imaging and echocardiography data. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):506-511

Prognostic role of frailty in early and long-term prognosis after coronary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):512-518

Pulsatile versus non-pulsatile flow during cardiopulmonary bypass and its impact on microcirculation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):595-601

Left anterior descending artery and diagonal branch bypass in multiple-vessel coronary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):646-650

Moderate ischemic mitral insufficiency with severe left ventricular dysfunction: surgical treatment depending on predictors of adverse long-term outcomes. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):651-659

Stentectomy following percutaneous coronary intervention complicated by perforation of distal anastomosis after previous coronary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):109-114

Rehabilitation potential of patients with ischemic heart disease who underwent autovenous coronary artery bypass surgery in the evaluation of rehabilitation treatment effectiveness. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):29-39

Assessment of real myocardial energy demand using indirect calorimetry in early postoperative period after cardiac surgery. Pirogov Russian Journal of Surgery. 2024;(12-2):50-57

A balance between surgical management and therapy in a patient with severe sternomediastinitis complicated by heart failure and refractory septic shock. Pirogov Russian Journal of Surgery. 2024;(12-2):166-172

Hemodynamic parameters of venous return and their role in assessment of fluid responsiveness in cardiac surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):6-12

Abstract:

In this study we performed a comparative analysis of using intraoperative IABP and levosimendan in high risk cardiac patients (LVEF<35%) operated under CPB. In 10 patients, intra-aortic balloon pump was started immediately after induction of anesthesia; another 10 had a levosimendan infusion starting after induction of anesthesia with an initial bolus of 12 mg/kg-1 for 10 min, followed by 0.1 mg/kg-1 min-1for 24 h. Hemodynamics, troponin I levels, postoperative complications were analyzed. It was shown that the use of intraoperative IABP and levosimendan are effective ways of circulatory support. In addition, the use of levosimendan reduces the length of intensive care unit stay and hospitalization.

Keywords:

cardiopulmonary bypass

coronary artery bypass grafting

heart failure

intra-aortic balloon pump

levosimendan

Authors:

Lomivorotov V.V.

E.N.Meshalkin National Medical Research Center under the Ministry of Health of the Russia, Novosibirsk, 630055, Russia

ORCID: 0000-0001-8591-6461

Boboshko V.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Boboshko A.V.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Cherniavskiĭ A.M.

Novosibirskiĭ NII patologii krovoobrashcheniia im. akad. E.N. Meshalkina;
Rossiĭskiĭ kardiologicheskiĭ nauchno-proizvodstvennyĭ kompleks Minzdravsotsrazvitiia Rossii, Moskva

Nikolaev D.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Kornilov I.A.

FGBU "Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina" Minzdrava RF

Shilova A.N.

Department of Vascular Surgery, E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Novosibirsk

Lomivorotov V.N.

FGBU Novosibirskiĭ nauchno-issledovatel'skiĭ institut patologii krovoobrashcheniia im. akad. E.N. Meshalkina Minzdrava Rossii

Close metadata

References:

Eremenko A.A., Zyulyaeva T.P., Babaev M.A. i dr. Vnutriaortal'naya ballonnaya kontrpul'satsiya v lechenii infarkta miokarda, oslozhnennogo kardiogennym shokom, pri operatsiyakh aortokoronarnogo shuntirovaniya. Anesteziol reanimatol 2010; 2: 40-44.
Eremenko A.A., Kolpakov V.E., Babaev M.A. i dr. Primenenie levosimendana u kardiokhirurgicheskikh bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu. Anesteziol reanimatol 2010; 2: 24-26.
Lomivorotov V.V., Boboshko V.A., Chernyavskii A.M. i dr. Sravnitel'naya otsenka profilakticheskogo ispol'zovaniya vnutriaortal'noi ballonnoi kontrpul'satsii i levosimendana u patsientov IBS s nizkoi fraktsiei vybrosa levogo zheludochka. Patol krovoobr i kardiokhir 2011; 2: 49-54.
Adams J.E. 3rd, Bodor G.S., Dávila-Román V.G. et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 1: 101-106.
Adams K.F. Jr, Fonarow G.C., Emerman C.L. et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 2: 209-216.
Bream-Rouwenhorst H.R., Hobbs R.A., Horwitz P.A. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Int Cardiol 2008; 21: 4: 350-356.
Caparrelli D.J., Ghazoul M., Diethrich E.B. Indications forcoronary artery bypass graftingin 2009: what is left to surgery. J Cardiovasc Surg (Torino) 2009; 50: 1: 19-28.
Cohen M., Urban P., Christenson J.T. et al. Benchmark Registry Collaborators. Intra-aortic balloon counterpulsationin US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003; 24: 19: 1763-1770.
De Hert S.G., Lorsomradee S., Eede H. et al. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J CardiothoracVasc Anesth 2008; 22: 699-705.
Den Uil C.A., Valk S.D., Cheng J.M. et al. Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counter pulsation prior to surgery: along-termfollow-up study. Int Cardiovasc Thorac Surg 2009; 9: 2: 227-231.
Ferguson J.J.3rd, Cohen M., Freedman R.J.Jr. et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001; 38: 5: 1456-1462.
Hönisch A., Theuring N., Ebner B. et al. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 2010; 105: 155-167.
Hunt S.A., Baker D.W., Chin M.H. et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104: 24: 2996-3007.
Kersten J.R., Montgomery M.W., Pagel P.S., Warltier D.C. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels. Anesth Analg 2000; 90: 1: 5-11.
Labriola C., Siro-Brigiani M., Carrata F. et al. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 2004; 42: 4: 204-211.
Landoni G., Mizzi A., Biondi-Zoccai G. et al. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol 2010; 76: 4: 276-286.
Lavana J.D., Fraser J.F., Smith S.E. et al. Influence of timing of intraaortic balloon placement in cardiac surgical patients. J ThoracCardiovasc Surg 2010; 140: 1: 80-85.
Lomivorotov V.V., Boboshko V.A., Efremov S.M. et al. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J CardiothoracVasc Anesth 2012; 26: 4: 596-603.
Meco M., Gramegna G., Yassini A. et al. Mortalityandmorbidityfromintra-aorticballoonpumps. Risk analysis. J Cardiovasc Surg (Torino) 2002; 43: 1: 17-23.
Mickleborough L.L., Carson S., Tamariz M., Ivanov J. Results of revascularization in patients with severe left ventricular dysfunction. J ThoracCardiovasc Surg 2000; 119: 3: 550-755.
O'Connor C.M., Velazquez E.J., Gardner L.H. et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002; 90: 2: 101-107.
Ramnarine I.R., Grayson A.D., Dihmis W.C. et al. Timing of intra-aortic balloon pump support and 1-year survival. Eur J Cardiothorac Surg 2005; 27: 5: 887-892.
Severi L., Lappa A., Landoni G. et al. Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients. J Cardiothorac Vasc Anesth 2011; 25: 4: 632-636.
Slawsky M.T., Colucci W.S., Gottlieb S.S. et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 18: 2222-2227.